Which of the following is a common treatment for Kawasaki disease?

The treatment of choice for Kawasaki disease is intravenous immunoglobulin (IVIG). This condition is characterized by systemic vasculitis, predominantly affecting children, and can lead to serious complications such as coronary artery aneurysms if left untreated. IVIG has been shown to reduce the risk of these cardiovascular issues by modulating the immune response and reducing inflammation. In conjunction with aspirin, IVIG effectively alleviates the symptoms of Kawasaki disease and promotes recovery.

While ibuprofen may be used for supportive care to relieve fever and discomfort, it is not a primary treatment for Kawasaki disease. Antibiotics play no role in treating Kawasaki disease as it is not caused by a bacterial infection, and SSRIs are unrelated to the management of this autoimmune condition. Thus, IVIG stands out as the most critical intervention in the treatment of Kawasaki disease.